Invention Grant
- Patent Title: Cyclic dinucleotides as anticancer agents
-
Application No.: US16047071Application Date: 2018-07-27
-
Publication No.: US10744150B2Publication Date: 2020-08-18
- Inventor: Brian E. Fink , Dharmpal S. Dodd , Lan-ying Qin , Zheming Ruan , Yufen Zhao , Lalgudi S. Harikrishnan , Muthoni G. Kamau , Steven J. Walker
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Elliott Korsen
- Main IPC: C07H19/20
- IPC: C07H19/20 ; C07H19/23 ; C07H19/207 ; C07H19/14 ; C07H21/04 ; A61K31/7084 ; A61P35/02 ; A61P35/00 ; A61K45/06
Abstract:
The present invention is directed to compounds of the formulae I, II and III as shown below wherein all substituents are defined herein, as well as pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositions in the treatment of various disorders.
Public/Granted literature
- US20190030057A1 CYCLIC DINUCLEOTIDES AS ANTICANCER AGENTS Public/Granted day:2019-01-31
Information query
IPC分类:
